| |
| September 2007 |
| Cover Story |
Process Engineering |
Contract Services |
INDIA ON TRIAL
India, with its cost advantages and bank of educated professionals, has much to offer the clinical trials industry. However, some pharmaceutical companies are not yet convinced that clinical data in India and the available pool of trial subjects match their exacting standards. World Pharmaceutical Frontiers talks to four leading clinical trials specialists about what attracts pharmaceutical companies to India, and what problems the country must still overcome if it is to fulfil its huge potential. more... |
PAT: WORTH THE RISK
Regulators in the Us have offered attractive incentives to companies in pharmaceutical and biotechnology markets for the implementation of process analytical technology. Jim Banks
asks Mel Koch of the University of Washington and ted Gopal of Genentech why drug producers
remain so hesitant to invest.
more... |
A QUESTION OF TRUST
Pharmaceutical companies have been quick to pair up with contract manufacturing organisations to improve the efficiency of their production processes and gain
competitive advantage. However, there are those who feel such relationships could generate much more value if they were better managed. Jim Banks reports. more... |
| Drug Discovery |
Drug Delivery |
ALL IN THE DETAIL
Molecular imaging is allowing pharmaceutical researchers to improve drug development at the
molecular level, enabling earlier disease diagnosis and better follow-up care. Holger Grüll and Oliver C Steinbach of the department of bio-molecular engineering at Philips Research Laboratories outline some of the ways in which molecular imaging is making a difference. more... |
COLD COMFORT
With the market for temperature-sensitive pharmaceuticals and
biotechnology products set to increase substantially, the task of
managing these products from the factory gate to the end-user
will become increasingly difficult. Nigel Ash reports.
more... |
THE STICKY SOLUTION TO DRUG DELIVERY
It is widely used and often abused, but chewing gum is now being seen as a useful way of administering medication. Dr Barbara Conway outlines the benefits of chewing gum as a vehicle for drug delivery.
more... |
| Drug Delivery |
IT & Data Management |
Chemical Outsourcing |
IS IT TIME FOR A BREATH OF FRESH AIR?
At present aerosol devices intended for the delivery of drugs follow the same design, aimed at delivering medication to a patient at the required dosage. However, these devices fail to take into account the age of the patients as well as an array of other factors.
more...
|
BREAK BARRIERS
DATA BARRIERS
New global standards in data collection and exchange are making possible truly global clinical trials, writes Anthony J Costello of clinical research specialists, Nextrials, Inc.
more... |
CHEMICAL REACTION
New European legislation covering the production and use
of chemical substances came into force in June. Nic Paton
hears two rather different views on the implications of the
regulations for the pharmaceutical industry.
more... |
| Packaging |
Pharma Survey |
Regional Focus |
PACKAGED FOR COMPLIANCE
Patient non-compliance costs billions of dollars each year and puts lives at risk. Tassilo Korab, executive director of the Healthcare Compliance Packaging Council, says the right packaging could have a greater effect on health than improving the actual medicines. more... |
THE COST OF A CURE
The damage that counterfeit drugs have done to patients, the pharmaceutical business and its reputation is one of the most serious issues facing the industry. World Pharmaceutical Frontiers looks at the worrying growth and geographical spread of this menace to the market.
more...
|
GROWTH AHEAD FOR SOUTHERN EUROPE
As the Southern European pharmaceutical market continues its upward stride, Dr Gordon Low, senior pharmaceutical analyst at Visiongain, takes an in-depth look at the state of the region’s pharmaceutical industry, tracing its history and looking to the future to see what developments are on the way. more... |
| Manufacturing |
Industry In Figures |
Clinical Trials |
TAME THE PAPER MONSTER
It will be a familiar sight to anyone in pharmaceutical management: the reams of paper and multiple stages associated with getting a facility documented, commissioned and qualified. Robert Chew, a member of the ISPE’s international board of directors has some good news on a new standard set to take some of the pain out of the process. more...
|
PHARMA BEST ON SUCCESS IN ONCOLOGY
Innovative, effective, but premium-priced, therapies are reshaping approaches to cancer treatment and outcomes. Graham Lewis of IMS Health reviews a market where an ever widening array of effective options has stakeholders impressed with success rates but growing increasingly concerned about costs. more...
|
INTERFACE FOR SUCCESS
Annette Bested Toft, director of clinical trial supply at Nycomed, examines the challenges of internal relationships from a clinical trial supply perspective.
more... |
